📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
0 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BULLISH
TOTAL VIEWS
116
MGNX Latest News & AI Sentiment Analysis
0 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 2 ARTICLES
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
MacroGenics (MGNX) received a $10 million milestone payment from Gilead Sciences (GILD) following Gilead's exercise of an option to...
MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
MacroGenics (MGNX) announced interim Phase 1 clinical results for MGC026, a B7-H3-directed antibody-drug conjugate (ADC) designed to...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice